Sanofi’s Mei becomes CMO at Editas

Genome editing company Editas Medicine Inc. (NASDAQ:EDIT) hired Baisong Mei as SVP and CMO. Mei was senior global project head in rare disease and rare blood disorders at Sanofi (Euronext:SAN; NASDAQ:SNY), before which he was therapeutic area head for hematology clinical development at Biogen Inc. (NASDAQ:BIIB).

Michael “Mike” Ullmann will retire as EVP and general counsel at Johnson & Johnson (NYSE:JNJ). Ullmann, who joined the company in 1989 as M&A attorney, will be succeeded by Elizabeth “Liz” Forminard, effective Oct. 17. Forminard has held several roles at the company for 16 years, most recently as worldwide VP leading the corporate governance function, and general counsel of pharmaceutical, consumer health and medical technology sectors...